Regulators will give it a thorough screening – and its tax implications will become a political football – but the merger of Pfizer Inc. (PFE ) and Allergan plc (AGN) announced Monday is likely to take place next year.
Get Premium to keep reading
This is a premium article. Please sign up for Dividend.com Premium to access this article and other Premium content.
Learn more
